UICC joins COVID-19 and Cancer Task Force

28 April 2020

UICC has joined a COVID-19 and Cancer Task Force to help assess the impact of COVID-19 on cancer outcomes and strengthen collaborations between infectious disease and cancer modellers.

Healthcare systems are experiencing extreme pressures due to the coronavirus pandemic. Medical resources and staff being diverted to respond to the crisis, lockdowns and quarantine are restricting access to cancer care (e.g. treatments delayed and cancer screening services cancelled), and reports are also emerging of disruptions to drug and equipment supply chains. Clinical trials and research projects are on hold, university campuses are closed, conferences are being postponed and many cancer organisations are facing up to an as yet unknown financial impact of the crisis.

The cancer community requires a better understanding of the consequences for future prevalence and mortality rates, the short- and long-term impact on the oncology workforce and, most importantly at the present time, what coronavirus means for patients with cancer - recognising, on the one hand, the potential increased risk of COVID-19 infection and, on the other, the uncertainty with regards to cancer as a comorbidity.

"The global COVID-19 pandemic simultaneously unites the world against a common threat, and highlights the massive differences between countries in terms of their capacity and willingness to act. We need data to understand the impact of our decisions now, and the more we share, the clearer the picture is likely to become"
– Diana Sarfati Interim Chief Executive, Cancer Control Agency, and University of Otago, New Zealand

The health community responses to the coronavirus pandemic to date have focused solely on the trajectory of the infection and mortality based on coronavirus interventions alone. Therefore, recognising the full spectrum of health, social and economic consequences of the pandemic and the importance of including all perspectives in infectious disease modelling approaches, UICC has joined a global taskforce with three identified priorities:

  1. To assess the impact of COVID-19 on cancer outcomes, with an emphasis on real-time analysis.
  2. To strengthen the collaboration between infectious disease and cancer modellers in the immediate and longer-term.
  3. To assess the national impact on frontline healthcare workers as the pandemic progresses.

“The social and economic consequences of COVID-19 will profoundly impact human health - well beyond immediate deaths from infection. The COVID-19 and Cancer Task Force brings together clinicians, investigators, advocates, and policy-makers from the global oncology community to understand how to respond to these challenges. One of the first steps will be to facilitate collection and sharing of high-quality health system data.”
– Professor Christopher Booth, Queen’s University Cancer Research Institute, Kingston, Canada

How can you contribute? 

The Task Force has developed a high-level survey to respond to priority one. UICC members are invited to contribute directly or share the survey with colleagues, using the survey on SurveyMonkey. Contributions are highly appreciated and should be submitted before Friday 15 May 2020

Priority two will be addressed by a modelling consortium. Please see here the call for Expressions of Interest for researchers interested in joining the consortium.

If your organisation has any queries, please contact:

Julie Torode, Director of Special Projects

Last update: 
Thursday 7 January 2021
Other coronavirus news and resources
Three women nurses wearing masks and showing a heart sign outside a health facility
12 May 2021

Nurses and frontline workers show resilience in an incredibly tough year

Frontline health workers have paid a heavy toll this past year. Marking International Nurses Day, it is important to look to the future and build the support they need to continue their invaluable work.

Despite the challenges oF COVID-19, CCS quickly found ways to adapt to the realities of COVID-19
5 January 2021

Facing a pandemic head on: How CCS took bold action to continue supporting the most vulnerable

CEO of the Canadian Cancer Society (CCS) Andrea Seale has been invited to share how her organisation found ways to ensure that Canadians affected by cancer were not alone during the pandemic.

Prof Anil D'Cruz, President of UICC 2020-2022 and Director at Oncology Apollo Hospitals, presents his vision for UICC and cancer care
4 January 2021

Towards a brighter 2021 – a vision for UICC and cancer control

A leading oncologist in India and UICC’s new President for 2020-2022, Professor Anil D’Cruz wishes UICC members and partners all the best for 2021 and outlines his vision for the organisation and cancer control, as he helps guide UICC through a changing health landscape.

Thinking Pink Breast Cancer Foundation is one of the only acting organisations in Sierra Leone working on raising awareness about breast cancer and bringing treatment to all Sierra Leoneans. Here, CEO Ms Pratt with former UICC presdient, Princess Dina Mired.
17 December 2020

How breast cancer patients in Sierra Leone are affected by COVID-19

In a country with extremely low resources, Thinking Pink Breast Cancer Foundation has made incredible strides and is now working to address the halt in treatments and funding due to COVID-19. Blog by its founder, Mrs Cremelda Parkinson Pratt.

The weekly number of breast cancer diagnoses are estimated to have fallen more than 50% during the pandemic. Image from the National Cancer Institute.
11 December 2020

Lessons from COVID-19: Addressing global cancer disparities

Head of Global Oncology Advocacy and Professional Relations at Daiichi Sankyo, Gissoo DeCotiis, discusses how COVID-19 has highlighted ongoing global disparities in breast cancer care and the continued need for action.

Smart investment in cancer care saves lives and is a net socio-economic benefit. Image from the Istanbul Oncology Institute, Turkey. © UICC 2015
8 December 2020

Cancer beyond COVID-19: Strengthening the case for investment in cancer control

In this third and final Virtual Dialogue dedicated to cancer care during the coronavirus pandemic and beyond, a panel of experts made the case for cost-efficient investment in healthcare and cancer control.